Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6335-80-4

Post Buying Request

6335-80-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6335-80-4 Usage

Description

ETHYL3-(BENZYLAMINO)BUTANOATE, with the molecular formula C13H19NO2, is a chemical ester compound derived from the reaction between an alcohol and an acid. It is recognized for its distinctive fruity and floral aroma, making it a valuable ingredient in the production of pharmaceuticals, perfumes, and flavorings. Additionally, it serves as a precursor in organic synthesis and a building block for the preparation of other organic compounds.

Uses

Used in Pharmaceutical Industry:
ETHYL3-(BENZYLAMINO)BUTANOATE is used as an active pharmaceutical ingredient for its potential therapeutic properties, contributing to the development of new medications.
Used in Perfumery:
ETHYL3-(BENZYLAMINO)BUTANOATE is used as a fragrance ingredient for its pleasant fruity and floral scent, enhancing the olfactory profile of various perfumes.
Used in Flavoring Industry:
ETHYL3-(BENZYLAMINO)BUTANOATE is used as a flavoring agent to impart a desirable taste and aroma to food and beverage products, adding depth and complexity to their flavor profiles.
Used in Organic Synthesis:
ETHYL3-(BENZYLAMINO)BUTANOATE is used as a precursor in organic synthesis, facilitating the creation of a range of other organic compounds for various applications.
Used in Building Blocks for Organic Compounds:
ETHYL3-(BENZYLAMINO)BUTANOATE serves as a building block in the preparation of other organic compounds, playing a crucial role in the synthesis of complex molecules for diverse industries.
It is important to handle ETHYL3-(BENZYLAMINO)BUTANOATE with care and follow proper safety protocols to minimize any potential hazards associated with its use.

Check Digit Verification of cas no

The CAS Registry Mumber 6335-80-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,3 and 5 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6335-80:
(6*6)+(5*3)+(4*3)+(3*5)+(2*8)+(1*0)=94
94 % 10 = 4
So 6335-80-4 is a valid CAS Registry Number.
InChI:InChI=1/C13H19NO2/c1-3-16-13(15)9-11(2)14-10-12-7-5-4-6-8-12/h4-8,11,14H,3,9-10H2,1-2H3

6335-80-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 3-(benzylamino)butanoate

1.2 Other means of identification

Product number -
Other names ethyl 3-(benzylamino)butyrate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6335-80-4 SDS

6335-80-4Relevant articles and documents

Development of a continuously operating process for the enantioselective synthesis of a b-amino acid ester via a solvent-free chemoenzymatic reaction sequence

Strompen, Simon,Weiss, Markus,Groeger, Harald,Hilterhaus, Lutz,Liese, Andreas

, p. 2391 - 2399 (2013)

A sequential, chemoenzymatic process for a continuously operating production of the chiral β-amino acid ester ethyl (S)-3-(benzylamino)- butanoate was developed. The reactor set-up combined a plug-flow reactor for the thermal aza-Michael addition of benzy

KRAS G12C Mutant protein inhibitors

-

Paragraph 0180-0185, (2021/11/26)

The invention discloses compounds which irreversibly inhibit KRAS G12C mutation. A pharmaceutically acceptable salt and of the compound contains the compound or a salt thereof, and the invention also discloses an application of the compound or a salt and of the compound in the treatment KRAS G12C of a proliferative disease such as a sudden tumor.

A piperidine compound and method for preparing the same

-

Paragraph 0029; 0031; 0040; 0049; 0059, (2018/02/04)

The invention relates to a piperidine compound and a preparation method thereof. The compound is 2-methyl-4-N-tert-butyloxycarboryl piperidine. The preparation method comprises the following steps of (1) adding a compound (1) ethyl crotonate and benzylami

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6335-80-4